Clinical Trials Directory

Trials / Completed

CompletedNCT02260206

Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion

Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Following Catheter Ablation of Atrial Fibrillation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Yong Seog Oh · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The effects colchicine administration for acute pericardial effusion after radiofrequency catheter ablation (RFCA) of atrial fibrillation on the recurrences of arrhythmia.

Detailed description

RFCA was started as a rhythm control of atrial fibrillation about 10 years before and the superiority of RFCA to medical treatment has been continuously reporting, so RFCA is globally performed nowadays. Acute pericardial effusion could occur during RFCA as complication, that might be developed to cardiac tamponade needed immediate pericardiocentesis. The inflammation developed after pericardiocentesis might be associated with the recurrences of atrial fibrillation, it could be presumed by the frequent occurrence of atrial fibrillation after open-heart surgery. The inflammation can be suppressed by administration of colchicine and the effects of colchicine have been proven to decrease the development of atrial fibrillation.

Conditions

Interventions

TypeNameDescription
DRUGColchicineImpact of Colchicine therapy on arrhythmia Recurrence after Acute Pericardial Effusion following Catheter Ablation of Atrial Fibrillation

Timeline

Start date
2014-07-01
Primary completion
2019-09-01
Completion
2023-10-01
First posted
2014-10-09
Last updated
2024-04-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02260206. Inclusion in this directory is not an endorsement.